Bimzelx 160 mg
Bimzelx 160 mg is a medicine authorised by Swissmedic under authorisation number 68548. The authorisation holder is UCB-Pharma SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 27 October 2022 and the authorisation is limited until 26 October 2027. ATC code L04AC21 places the medicine in the group Immunosuppressants.
| Authorisation number | 68548 |
|---|---|
| Name | Bimzelx 160 mg |
| Full name | Bimzelx 160 mg, solution injectable en seringue préremplie |
| Authorisation holder | UCB-Pharma SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AC21 |
| First authorisation | 27 October 2022 |
| Authorisation validity | 26 October 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bimzelx 160 mg, solution injectable en seringue préremplie | B | 27 October 2022 |
| 2 | Bimzelx 320 mg, solution injectable en seringue préremplie | B | 29 August 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | L04AC21 | 07.15.0. | B |
| 2 | 2 | Fertigspritze(n) | L04AC21 | 07.15.0. | B |
| 3 | 1 | Fertigspritze(n) | L04AC21 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Bimzelx 160 mg authorised in Switzerland?
Yes. Bimzelx 160 mg is authorised by Swissmedic under authorisation number 68548, data as of 01 September 2026. The authorisation is limited until 26 October 2027.
Which dispensing category does Bimzelx 160 mg have?
Bimzelx 160 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Bimzelx 160 mg?
The authorisation holder is UCB-Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.